The Patent Finder

Oxagen Limited

Also on record
Records under this name other than patents Oxagen Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Oxagen Limited

PatentTitleStatus Expires Confidence
US 7,750,027Compounds having CRTH2 antagonist activity
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,563,536Compounds having CRTH2 antagonist activity
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,536,158Compounds having CRTH2 antagonist activity
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,703,956Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-INDOL-1-YL)-Acetic Acid
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,011,584Polymorphic Form of [5-Fluoro-3-({2-[(4-Fluorobenzene) SULFONYL]PYRIDIN-3-YL}METHYL)-2-Methylindol-1-YL]-ACETIC Acid
Formerly held
Lapsed on the fee record
Ended Jul 3, 2026 · Medium confidence
Lapsed on the fee recordEnded Jul 3, 2026Medium confidence
US 9,951,042Polymorphic Form of [5-Fluoro-3-({2-[(4-Fluorobenzene) Sulfonyl] PYRIDIN-3-YL}METHYL)-2-Methylindol-1-YL]-ACETIC Acid
Formerly held
Lapsed on the fee record
Ended Apr 24, 2026 · High confidence
Lapsed on the fee recordEnded Apr 24, 2026High confidence
US 7,582,672Compounds for the treatment of CRTH2-mediated diseases and conditions
Formerly held
Term ended
Term ended Feb 8, 2026 · From the USPTO record
Term endedTerm ended Feb 8, 2026From the USPTO record
US 9,828,359Process for the preparation of 3-substituted (indol-1-yl)-acetic acid esters
Formerly held
Lapsed on the fee record
Ended Nov 28, 2025 · From the USPTO record
Lapsed on the fee recordEnded Nov 28, 2025From the USPTO record
US 8,314,257Treatment of CRTH2-mediated diseases and conditions
Formerly held
Lapsed on the fee record
Ended Nov 20, 2024 · From the USPTO record
Lapsed on the fee recordEnded Nov 20, 2024From the USPTO record
US 8,198,314Treatment of CRTH2-mediated diseases and conditions
Formerly held
Lapsed on the fee record
Ended Jun 12, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jun 12, 2024From the USPTO record
10 of 23 patents shown.
Pro members see all 23.
Pro members: see all 23 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited